Chinese technology firms and academic researchers are rapidly advancing the development of brain-computer interfaces (BCIs) designed to be implanted in approximately ten minutes. Unlike traditional BCI systems that require invasive neurosurgery to access the brain, these new devices are inserted through a vein, similar to the process used for a cardiac stent. The technology allows users to operate digital devices using neural signals, effectively translating thoughts into digital commands.

This push is part of a broader strategic effort by Beijing to cultivate a domestic BCI industry capable of competing with international leaders, most notably Elon Musk’s Neuralink. Companies such as StairMed Technology are at the forefront of this effort, focusing on minimizing the surgical risks associated with brain-machine integration. By utilizing endovascular approaches, these developers aim to make the technology more accessible to patients who might otherwise be deterred by the risks and recovery times associated with conventional open-brain procedures. While the technology is still in the developmental and early testing phases, the rapid pace of innovation reflects a national priority to establish China as a major player in the global neurotechnology market.